Scarica l'app Stockscreener
219.35
0.09%
-0.20
Precedente Chiudi:
$219.55
Aprire:
$219.45
Volume 24 ore:
1.31M
Relative Volume:
1.02
Capitalizzazione di mercato:
$6.90B
Reddito:
$302.00K
Utile/perdita netta:
$-117.10M
Rapporto P/E:
-19.71
EPS:
-11.13
Flusso di cassa netto:
$-129.13M
1 W Prestazione:
+0.75%
1M Prestazione:
+112.51%
6M Prestazione:
+735.62%
1 anno Prestazione:
+1,157%
Intervallo 1D:
$218.86
$219.90
Intervallo di 1 settimana:
$217.41
$220.41
Portata 52W:
$15.22
$220.41
Cidara Therapeutics Inc Stock (CDTX) Company Profile
Nome
Cidara Therapeutics Inc
Settore
Industria
Telefono
858-752-6170
Indirizzo
6310 NANCY RIDGE DRIVE, SAN DIEGO, CA
Confronta CDTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CDTX
Cidara Therapeutics Inc
|
219.35 | 6.90B | 302.00K | -117.10M | -129.13M | -11.13 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Cidara Therapeutics Inc Stock (CDTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-17 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-11-17 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-11-17 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-10-16 | Iniziato | Morgan Stanley | Overweight |
| 2025-10-10 | Iniziato | JP Morgan | Overweight |
| 2025-06-18 | Ripresa | H.C. Wainwright | Buy |
| 2025-03-12 | Iniziato | Citizens JMP | Mkt Outperform |
| 2025-01-27 | Ripresa | Cantor Fitzgerald | Overweight |
| 2024-12-13 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-11-08 | Iniziato | Guggenheim | Buy |
| 2024-08-14 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2021-12-03 | Ripresa | H.C. Wainwright | Buy |
| 2021-09-22 | Aggiornamento | WBB Securities | Buy → Strong Buy |
| 2021-03-04 | Iniziato | Aegis Capital | Buy |
| 2019-09-04 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2018-07-26 | Iniziato | Citigroup | Buy |
| 2017-04-21 | Iniziato | Raymond James | Strong Buy |
| 2017-04-17 | Reiterato | H.C. Wainwright | Buy |
| 2017-04-12 | Iniziato | Ladenburg Thalmann | Buy |
| 2017-04-11 | Ripresa | Wedbush | Outperform |
| 2017-02-22 | Reiterato | H.C. Wainwright | Buy |
| 2017-02-22 | Aggiornamento | WBB Securities | Sell → Hold |
| 2016-12-21 | Ripresa | Leerink Partners | Outperform |
| 2016-12-19 | Iniziato | H.C. Wainwright | Buy |
| 2016-09-23 | Downgrade | WBB Securities | Hold → Sell |
| 2015-10-09 | Aggiornamento | WBB Securities | Sell → Hold |
| 2015-05-11 | Iniziato | Jefferies | Buy |
| 2015-05-11 | Iniziato | Leerink Partners | Outperform |
| 2015-05-11 | Iniziato | Needham | Buy |
| 2015-05-11 | Iniziato | Wedbush | Outperform |
| 2015-04-23 | Iniziato | WBB Securities | Sell |
Mostra tutto
Cidara Therapeutics Inc Borsa (CDTX) Ultime notizie
Top Biotech Stocks To Watch TodayNovember 21st - MarketBeat
RedChip Companies Congratulates Former Client Cidara Therapeutics on Its $9.2 Billion Acquisition by Merck - Cheboygan Daily Tribune
10 Hottest SMID-Cap Stocks So Far In 2025 - Insider Monkey
Halper Sadeh LLC Encourages THS, CDTX, SPNS Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewswire
Halper Sadeh LLC Encourages THS, CDTX, SPNS Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewswire Inc.
Promising Biotech Stocks To ConsiderNovember 18th - MarketBeat
Promising Mid Cap Stocks To ConsiderNovember 17th - MarketBeat
(CDTX) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com
Top Biotech Stocks To ConsiderNovember 20th - MarketBeat
Jefferies 25: Merck’s Cidara Buyout Could Help Meet Needs Of Increasingly Vaccine-Hesitant US - Citeline News & Insights
Merck Invests $9.2B in Cidara to Boost Breakthrough Flu Drug - BUCKSCO.Today
Can Cidara Therapeutics Inc. stock surprise with earnings upside2025 Market Sentiment & Free Safe Entry Trade Signal Reports - newser.com
Will Cidara Therapeutics Inc. (20D0) stock hit Wall Street targetsWeekly Stock Report & Risk Controlled Swing Alerts - newser.com
Will Cidara Therapeutics Inc. stock deliver long term returnsWeekly Gains Report & Smart Money Movement Tracker - newser.com
Institutional Titan Hits the Jackpot: Biotech Stock Surges by 116% on Buyout Offer - AOL.com
Why Cidara Therapeutics Inc. stock could benefit from AI revolution2025 Winners & Losers & Verified Technical Signals - newser.com
Merck Is Buying Cidara Therapeutics for $9.2 Billion. Is This the Boost the Lagging Drugmaker Needs? - Finviz
Is AtriCure (ATRC) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Cidara Therapeutics Is Up Over 100%. Here's What Investors Need to Know. - Yahoo Finance
Merck deal shows potential of strain-agnostic flu protection - The Pharma Letter
Should you wait for a breakout in Cidara Therapeutics Inc.Market Risk Analysis & Short-Term High Return Ideas - newser.com
What to do if you’re stuck in Cidara Therapeutics Inc.Trend Reversal & Reliable Entry Point Alerts - newser.com
Will Cidara Therapeutics Inc. stock outperform international peersChart Signals & AI Optimized Trading Strategy Guides - newser.com
Is Cidara Therapeutics Inc. stock poised for growthEarnings Risk Report & Free Real-Time Volume Trigger Notifications - newser.com
Best Mid Cap Stocks To Add to Your WatchlistNovember 14th - MarketBeat
Using data models to predict Cidara Therapeutics Inc. stock movementMarket Performance Recap & Safe Entry Momentum Tips - newser.com
Merck's Cidara Buyout Is An Opportunistic Win For Both PartiesHere's Why (NASDAQ:CDTX) - Seeking Alpha
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Cidara ... - Black Hills Pioneer
Live market analysis of Cidara Therapeutics Inc.July 2025 Final Week & Risk Managed Investment Signals - newser.com
Cidara Therapeutics Inc Azioni (CDTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.38%
1.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):